合体InAs四足动物:表面活性剂对形状控制的影响
Zheming Liu1, Roberta Pascazio1, Luca Goldoni
1Dipartimento di Chimica e Chimica Industriale, Università di Genova, 16146 Genova, Italy.
Journal of the American Chemical Society
|August 23, 2023
概括
研究人员使用新型联体混合物合成了化 (InAs) 纳米晶体 (NC). 一种特定的三聚胺 (TOA) 和聚胺 (OA) 配体的比率产生了控制尺寸和形状的InAs四足动物.
科学领域:
- 材料科学
- 纳米技术
- 半导体物理
背景情况:
- 合体化物 (InAs) 纳米晶体 (NC) 对于光电子应用至关重要.
- 控制INAsNC的尺寸和形态是具有挑战性的传统配体,如烯胺 (OA).
研究的目的:
- 探索合成INANC的替代配体.
- 为了控制大小分布和特定的形态,如四足动物.
- 了解连接物混合物在INANC形成中的作用.
主要方法:
- 使用各种配体,包括三聚胺 (TOA) 和OA合成InANCs.
- 使用吸收和光发光谱的NC大小,形状和光学特性.
- 使用核磁共振 (NMR) 分析连接体被动化.
- 使用分子动力学 (MD) 模拟来研究生长机制.
主要成果:
- 碳酸和酸只产生氧化物.
- 像TOA这样的单个配体导致了广泛的尺寸分布.
- 混合TOA和OA提供了良好的尺寸控制.
- 具有5-6 nm臂的特制产生的TOA:OA比率为4:1.
- 在As四足动物表现出混合结构与111方向的臂.
- 光学特性显示在~950nm的激发峰值和在1050nm的辐射.
- 波段间隙主要取决于臂>3 nm的核心大小.
- 核磁共振显示OA是主要的表面连接体.
- MD模拟显示OA与面部结合,TOA与边缘/角部结合,促进四足动物的生长.
结论:
- 基混合物,特别是TOA:OA比率,可以对INAsNC合成进行增强的控制.
- 联合使用OA和TOA有助于InAs四足动物的形成.
- 了解连接物-表面相互作用是定制NC属性的关键.
相关概念视频
01:29The Colloidal State
184
The formation of a colloidal system is exemplified by an aqueous solution containing Cl− ions is introduced to another containing Ag+ ions, resulting in the precipitation of solid AgCl as extremely tiny crystals. Instead of settling out as a filterable precipitate, these crystals remain suspended in the liquid, showcasing a colloidal system.A colloidal system involves colloidal particles within the approximate range of 1 to 1000 nm in at least one dimension, dispersed in a medium called...
184
01:27Surface Active Agents
158
Surfactants, named for their behavior at interfaces, positively adsorb at the interfaces of two phases, reducing interfacial tension. Their versatility as emulsifiers, detergents, and foaming agents stems from this ability. Surfactants, often termed amphiphiles, share the property of amphipathy, with molecules having both hydrophilic and hydrophobic portions. The hydrophilic part is called the head, and the hydrophobic part, including an elongated alkyl substituent, forms the tail.Surfactants...
158
01:28Factors Influencing Drug Absorption: Pharmaceutical Parameters
834
Solid dosage forms such as tablets and capsules undergo rigorous manufacturing processes to ensure stability and effectiveness. Their dissolution and absorption properties are influenced significantly by the choice of excipients (inactive ingredients that serve various roles in the formulation), and the methodology applied during production. The manufacturing parameters, such as compression force and granulation techniques, significantly affect dissolution rates. Elevated compression forces...
834
01:27Pharmaceutical Alternatives: Polymorphic Form-Related and Particle Size-Related Therapeutic Nonequivalence
226
Changes in polymorphic forms can significantly influence the bioavailability of poorly soluble drugs. Although the FDA defines pharmaceutical equivalence based on having the same active ingredient, dosage form, and route of administration, it does not automatically disqualify products with different polymorphic forms. This means two products with different polymorphs can still be deemed pharmaceutically equivalent. However, polymorphic differences can affect properties like wettability,...
226
01:18Formulation and Manufacturing Process: Physical Attributes of Generic Tablets and Capsules
420
Bioequivalence in generic drugs, such as tablets and capsules, refers to their pharmaceutical equivalence to the brand-name counterparts. However, for therapeutic equivalence, manufacturers must also consider physical attributes like size, shape, and weight (FDA Guidance for Industry, December 2003). Discrepancies in these aspects could impact patient compliance and cause medication errors. For instance, swallowing difficulties, often experienced with larger tablets or capsules, can lead to...
420